Related Experiment Videos
Mode of action of torilin in multidrug-resistant cancer cell lines
1Natural Product Biosynthesis RU., Korea Research Institute of Bioscience and Biotechnology, Yusong, Taejon, Korea.
Abstract:
The mechanism of action of multidrug-resistance reversing activity of torilin was studied. In vitro experiments for the accumulation and efflux of vinblastine clearly indicated that MDR reversing effects of torilin would directly be associated with the increase of the intracellular accumulation of anticancer drugs by blocking the drug efflux. Furthermore, torilin increased the membrane ATPase activity from KB-V1 cells, suggesting that torilin might function by inhibiting drug transport mediated by P-glycoprotein.
Insights
Torilin reverses multidrug resistance by blocking cancer drug efflux, increasing intracellular drug accumulation. This suggests torilin inhibits P-glycoprotein, a key transporter in multidrug resistance (MDR).
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
- P-glycoprotein (P-gp) is a key efflux pump contributing to MDR.
- Torilin is a compound with potential MDR-reversing activity.
Purpose of the Study:
- To elucidate the mechanism of action of torilin in reversing multidrug resistance.
- To investigate whether torilin affects the efflux of anticancer drugs.
- To determine the potential role of P-glycoprotein in torilin's activity.
Main Methods:
- In vitro experiments measuring vinblastine accumulation and efflux in cancer cells.
- Assay of membrane ATPase activity in KB-V1 cells.
Main Results:
- Torilin significantly increased intracellular accumulation of vinblastine by blocking its efflux.
- Torilin enhanced membrane ATPase activity in KB-V1 cells.
- Results suggest torilin interferes with drug efflux mechanisms.
Conclusions:
- Torilin's MDR-reversing activity is linked to increased intracellular anticancer drug accumulation.
- Torilin may inhibit drug efflux by targeting P-glycoprotein-mediated transport.
- Torilin shows promise as an adjuvant therapy to overcome MDR in cancer treatment.